These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1516 related articles for article (PubMed ID: 25652589)

  • 21. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
    Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
    Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children.
    Dobaño C; Quelhas D; Quintó L; Puyol L; Serra-Casas E; Mayor A; Nhampossa T; Macete E; Aide P; Mandomando I; Sanz S; Puniya SK; Singh B; Gupta P; Bhattacharya A; Chauhan VS; Aponte JJ; Chitnis CE; Alonso PL; Menéndez C
    Clin Vaccine Immunol; 2012 Feb; 19(2):157-66. PubMed ID: 22169088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naturally acquired antibody responses to the components of the Plasmodium falciparum merozoite surface protein 1 complex.
    Wang L; Crouch L; Richie TL; Nhan DH; Coppel RL
    Parasite Immunol; 2003; 25(8-9):403-12. PubMed ID: 14651587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of crude Plasmodium falciparum antigens for comparison of antibody responses in patients with mild malaria vs. cerebral malaria.
    Mbengue B; Niang B; Diatta B; Tall A; Garraud O; Perraut R; Dieye A
    Iran J Immunol; 2010 Sep; 7(3):150-61. PubMed ID: 20876986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1.
    Rodrigues MH; Rodrigues KM; Oliveira TR; Cômodo AN; Rodrigues MM; Kocken CH; Thomas AW; Soares IS
    Int J Parasitol; 2005 Feb; 35(2):185-92. PubMed ID: 15710439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acquisition of antibodies to merozoite surface protein 3 among residents of Korogwe, north eastern Tanzania.
    Segeja MD; Mmbando BP; Seth MD; Lusingu JP; Lemnge MM
    BMC Infect Dis; 2010 Mar; 10():55. PubMed ID: 20205959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies to Plasmodium falciparum merozoite surface protein-1p19 malaria vaccine candidate induce antibody-dependent respiratory burst in human neutrophils.
    Joos C; Varela ML; Mbengue B; Mansourou A; Marrama L; Sokhna C; Tall A; Trape JF; Touré A; Mercereau-Puijalon O; Perraut R
    Malar J; 2015 Oct; 14():409. PubMed ID: 26471813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune responses elicited by co-immunization of Plasmodium vivax and P. falciparum MSP-1 using prime-boost immunization strategies.
    Mehrizi AA; Zakeri S; Rafati S; Salmanian AH; Djadid ND
    Parasite Immunol; 2011 Nov; 33(11):594-608. PubMed ID: 21883290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
    Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoglobulin G antibodies to merozoite surface antigens are associated with recovery from chloroquine-resistant Plasmodium falciparum in Gambian children.
    Pinder M; Sutherland CJ; Sisay-Joof F; Ismaili J; McCall MB; Ord R; Hallett R; Holder AA; Milligan P
    Infect Immun; 2006 May; 74(5):2887-93. PubMed ID: 16622227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody responses within two leading Plasmodium vivax vaccine candidate antigens in three geographically diverse malaria-endemic regions of India.
    Kale S; Yadav CP; Rao PN; Shalini S; Eapen A; Srivasatava HC; Sharma SK; Pande V; Carlton JM; Singh OP; Mallick PK
    Malar J; 2019 Dec; 18(1):425. PubMed ID: 31842894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production and preclinical evaluation of Plasmodium falciparum MSP-119 and MSP-311 chimeric protein, PfMSP-Fu24.
    Gupta PK; Mukherjee P; Dhawan S; Pandey AK; Mazumdar S; Gaur D; Jain SK; Chauhan VS
    Clin Vaccine Immunol; 2014 Jun; 21(6):886-97. PubMed ID: 24789797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.
    Singh S; Miura K; Zhou H; Muratova O; Keegan B; Miles A; Martin LB; Saul AJ; Miller LH; Long CA
    Infect Immun; 2006 Aug; 74(8):4573-80. PubMed ID: 16861644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of naturally acquired antibody responses against the C-terminal processing products of Plasmodium vivax Merozoite Surface Protein-1 under low transmission and unstable malaria conditions in Sri Lanka.
    Wickramarachchi T; Illeperuma RJ; Perera L; Bandara S; Holm I; Longacre S; Handunnetti SM; Udagama-Randeniya PV
    Int J Parasitol; 2007 Feb; 37(2):199-208. PubMed ID: 17055511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variation in the immune responses against Plasmodium falciparum merozoite surface protein-1 and apical membrane antigen-1 in children residing in the different epidemiological strata of malaria in Cameroon.
    Kwenti TE; Moye AL; Wiylanyuy AB; Njunda LA; Nkuo-Akenji T
    Malar J; 2017 Nov; 16(1):453. PubMed ID: 29121929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgG antibody profile to c-terminal region of Plasmodium vivax merozoite surface protein-1 in Thai individuals exposed to malaria.
    Pitabut N; Panichakorn J; Mahakunkijcharoen Y; Hirunpetcharat C; Looareesuwan S; Khusmith S
    Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):1-7. PubMed ID: 17539238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.
    Schwenk R; DeBot M; Porter M; Nikki J; Rein L; Spaccapelo R; Crisanti A; Wightman PD; Ockenhouse CF; Dutta S
    PLoS One; 2014; 9(10):e111020. PubMed ID: 25343487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Humoral immune response to Plasmodium falciparum vaccine candidate GMZ2 and its components in populations naturally exposed to seasonal malaria in Ethiopia.
    Mamo H; Esen M; Ajua A; Theisen M; Mordmüller B; Petros B
    Malar J; 2013 Feb; 12():51. PubMed ID: 23383869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial correlation of immunoglobulin G subclass responses to Plasmodium falciparum antigens in Burkina Faso.
    Aucan C; Traoré Y; Fumoux F; Rihet P
    Infect Immun; 2001 Feb; 69(2):996-1001. PubMed ID: 11159995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of antigen-specific immunoglobulin G subclasses in response to conserved and polymorphic Plasmodium falciparum antigens in an in vitro model.
    Garraud O; Perraut R; Diouf A; Nambei WS; Tall A; Spiegel A; Longacre S; Kaslow DC; Jouin H; Mattei D; Engler GM; Nutman TB; Riley EM; Mercereau-Puijalon O
    Infect Immun; 2002 Jun; 70(6):2820-7. PubMed ID: 12010968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 76.